[28HS1-pm] Pharmacotherapies (Basics) 2

Tue. Mar 28, 2023 2:00 PM - 3:00 PM [Room HS1] (1F)

Chair: Tomoka Takatani-Nakase, Kentaro Oniki

+Add all to schedule

2:00 PM - 2:12 PM

[28HS1-pm01] Dual blockade of endothelin and angiotensin II type 1 receptors could be an effective novel approach for the treatment of IgAN

○Hajime Nagasawa^1,2, Seiji Ueda¹, Hitoshi Suzuki^1,3, Celia Jenkinson⁴, Tomoyuki Otsuka¹, Teruyuki Okuma¹, Yusuke Fukao¹, Maiko Nakayama¹, Kai Liu⁴, Radko Komers⁴, Yusuke Suzuki¹ (1. Department of Nephrology, Juntendo University Faculty of Medicine, 2. Department of Nephrology, Juntendo University Shizuoka Hospital, 3. Department of Nephrology, Juntendo University Urayasu Hospital, 4. Travere Therapeutics, Inc)

2:12 PM - 2:24 PM

[28HS1-pm02S] Effects of erythropoietin on glucose intolerance and organ damage in insulin resistance model rats

○Kyohei Takizawa¹, Hiroe Toba¹, Miyuki Kobara¹, Tetsuo Nakata¹ (1. Kyoto Pharm. Univ.)

2:24 PM - 2:36 PM

[28HS1-pm03S] Role of SPARC in hypertensive vascular injury

○Sota Sakamoto¹, Hiroe Toba¹, Miyuki Kobara¹, Tetsuo Nakata¹ (1. Kyoto Pharm. Unniv.)

2:36 PM - 2:48 PM

[28HS1-pm04S] Study on the crude drug constituents in Kampo medicines (12) Quantitative analysis of sennosides A and B in Kampo decoctions and ethical Kampo extract formulations

○Tamami Shimazaki¹, Tomoki Iguchi¹, Marika Suzuki¹, Takashi Shii^1,2, Minpei Kuroda¹, Yoshihiro Mimaki¹ (1. Tokyo University of Pharmacy and Life Sciences, 2. Kitasato University Hospital)

2:48 PM - 3:00 PM

[28HS1-pm05] Stoichiometric modulation in the shuttle-sink model of cyclodextrin for the optimization of Niemann-Pick disease type C treatment

○Yusei Yamada^1,2, Madoka Nishizawa², Asami Nishiyama², Akira Ishii², Tatsuya Kawata², Aina Shirakawa², Masaki Nakashima², Yuki Kondo², Toru Takeo³, Naomi Nakagata³, Toru Miwa⁴, Hiroki Takeda⁵, Yorihisa Orita⁵, Taishi Higashi², Keiichi Motoyama², Hidetoshi Arima⁶, Takahiro Seki⁷, Yuki Kurauchi², Hiroshi Katsuki², Katsumi Higaki⁸, Kentaro Minami¹, Naoki Yoshikawa¹, Ryuji Ikeda¹, Muneaki Matsuo⁹, Tetsumi Irie², Yoichi Ishitsuka² (1. Dep. Pharm., Miyazaki Univ. Hosp., 2. Grad. Sch. Pharm. Sci., Kumamoto Univ., 3. Inst. Resour. Dev. Anal., Kumamoto Univ., 4. Grad. Sch. Med., Osaka Metropolitan Univ., 5. Grad. Sch. Med., Kumamoto Univ., 6. Daiichi Univ. Pharm., 7. Grad. Sch. Pharm., Himeji Dokkyo Univ., 8. Res. Initiat. Ctr., Tottori Univ., 9. Fac. Med., Saga Univ.)

Session information